FIELD: medicine.
SUBSTANCE: invention refers to medicine, and it can be used for treating dislipoproteinemia and atherosclerosis. For this purpose benzene sulphonate 1-methyl-3-ethyl is applied, 4,5 (bis-N-methylcarbamoyl) of imidazolium as a hypolipidemic and antiatherosclerotic agent for treatment of atherogenic dislipoproteinemia and atherosclerosis of various localizations.
EFFECT: invention allows to reduce level of cholesterol and triglycerides in blood serum, it reduces the atherosclerotic aorta and has low toxicity.
1 cl, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
| HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
| HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
| AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
| AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING HEPATOPROTECTING, HYPOLIPIDEMIC, IMMUNOSTIMULATING AND NORMALISING KIDNEY FUNCTION ACTION, AND METHOD OF ITS OBTAINING | 2011 |
|
RU2483712C2 |
| ANTI-ISCHEMIC AND ANTI-ATHEROSCLEROTIC DRUG | 1998 |
|
RU2144822C1 |
| METHOD FOR DIAGNOSING LIPIDEMIA | 2019 |
|
RU2694531C1 |
| METHOD FOR ASSESSING THE EFFECTIVENESS OF THE TREATMENT OF LIPIDEMIA | 2019 |
|
RU2694534C1 |
| DIAGNOSTIC TECHNIQUE FOR EARLY AND LATE STAGES OF LIPIDEMIA | 2019 |
|
RU2694538C1 |
Authors
Dates
2016-09-20—Published
2015-07-14—Filed